Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

19.1K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

88.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
88.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

4.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances and clinical relevance of microbiome dynamics in health and disease.

Gut microbes·2026
Same author

Diet and microbiome shape small-molecule cytokinin pools in mammals.

Gut microbes·2026
Same author

Integrated Multi-Tissue Transcriptomics Reveals Antagonistic Pleiotropy in Aging and Alzheimer's Disease.

Computational and structural biotechnology journal·2026
Same author

Automatic Coregistration of High-Resolution MALDI-MSI and Raman Imaging Applied to Cardiac Tissue of Fabry Disease Mouse Models.

Analytical chemistry·2026
Same author

RNA motifs, RNA structure, and motif context analyzed by RNAanalyzer3.

Nucleic acids research·2026
Same author

Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic Model.

Vaccines·2026
Same journal

Imbalance in amino acid and purine metabolisms at the hypothalamus in inflammation-associated depression by GC-MS.

Molecular bioSystems·2017
Same journal

Correction: Dynamic properties of dipeptidyl peptidase III from Bacteroides thetaiotaomicron and the structural basis for its substrate specificity - a computational study.

Molecular bioSystems·2017
Same journal

Conformational heterogeneity in tails of DNA-binding proteins is augmented by proline containing repeats.

Molecular bioSystems·2017
Same journal

Mechanism of the formation of the RecA-ssDNA nucleoprotein filament structure: a coarse-grained approach.

Molecular bioSystems·2017
Same journal

Staphylococcus aureus extracellular vesicles (EVs): surface-binding antagonists of biofilm formation.

Molecular bioSystems·2017
Same journal

Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.

Molecular bioSystems·2017
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

10.9K

Analyzing ERK 1/2 signalling and targets.

Alexandra Brietz1, Kristin Verena Schuch1, Gaby Wangorsch1

  • 1Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany. dandekar@biozentrum.uni-wuerzburg.de.

Molecular Biosystems
|June 16, 2016
PubMed
Summary
This summary is machine-generated.

The ERK pathway protects the heart but can harm it. Targeting ERK phosphorylation offers a new way to treat heart conditions like hypertrophy and failure.

More Related Videos

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

8.4K
Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

19.5K

Related Experiment Videos

Last Updated: Mar 19, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
08:40

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

Published on: November 29, 2016

10.9K
Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

8.4K
Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

19.5K

Area of Science:

  • Cardiovascular Biology
  • Molecular Signaling
  • Computational Biology

Background:

  • The extracellular signal-regulated kinase (ERK) cascade, including Raf-1, plays a dual role in cardiac protection and maladaptation.
  • Specific ERK phosphorylation sites, such as ERK2 at Thr188, enable nuclear signaling linked to cardiac hypertrophy.

Purpose of the Study:

  • To develop and validate an in silico model of the ERK cascade.
  • To investigate ERK phosphorylation states and their role in hypertrophic versus non-hypertrophic cardiac stimuli.
  • To identify novel ERK targets and interaction partners in pathological cardiac remodeling.

Main Methods:

  • Construction and setup of a computational model for ERK 1/2 phosphorylation states.
  • Simulation of synergistic and antagonistic receptor stimuli.
  • Experimental validation using gene expression data and time courses in chronic heart failure models.

Main Results:

  • The in silico model accurately predicted synergistic and antagonistic stimuli, with validated time courses.
  • New nuclear targets of ERK 1/2 involved in pathological hypertrophy were identified.
  • Key components and novel interaction partners in the ERK cascade were supported by experimental data.

Conclusions:

  • The developed computational model provides a valuable tool for studying ERK signaling in the heart.
  • Targeting specific ERK phosphorylation, particularly at Thr188, presents a promising therapeutic strategy for cardiac hypertrophy and failure.
  • Further research into novel ERK targets and interaction partners may reveal new insights into cardiac disease mechanisms.